Active ingredientFondaparinuxCat. No. P-F112-001CAS 104993-28-4Family · Pharmaceutical analytical standards
Fondaparinux
A synthetic anticoagulant approved in 2001 in the United States and in 2002 in Europe: it helps antithrombin block factor Xa and is used to prevent and treat venous thrombosis and pulmonary embolism. This family brings together the active ingredient and other impurities.
Did you know?It is made only by chemical synthesis: it reproduces the five-sugar sequence that heparin, extracted from animal tissue, uses to grip antithrombin, with just one extra methyl group.
Go to the active ingredient →Active ingredientFondaparinuxCat. No. P-F112-001CAS 104993-28-4
Active ingredientFondaparinux SodiumCat. No. P-F112-002CAS 114870-03-0
ImpurityFondaparinux Impurity 1Cat. No. P-F112-003CAS 348625-84-3
ImpurityFondaparinux Impurity 2Cat. No. P-F112-016
ImpurityFondaparinux Impurity 3Cat. No. P-F112-017CAS 256348-55-7
ImpurityFondaparinux Impurity 4Cat. No. P-F112-018
ImpurityFondaparinux Impurity 5Cat. No. P-F112-019
ImpurityFondaparinux Impurity 6Cat. No. P-F112-020
ImpurityFondaparinux Impurity 7Cat. No. P-F112-022
ImpurityFondaparinux Impurity 8Cat. No. P-F112-023CAS 2088176-32-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.